$NUVB ($NUVB) posted quarterly earnings results for Q4 2025 on Monday, March 2nd. The company reported earnings of -$0.11 per share, missing estimates of -$0.09 by $0.02. The company also reported revenue of $41,870,000, beating estimates of $38,072,622 by $3,797,378.
Stock price change since market close: -5.99%
You can see Quiver Quantitative's $NUVB stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
$NUVB Insider Trading Activity
$NUVB insiders have traded $NUVB stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $NUVB stock by insiders over the last 6 months:
- GARY HATTERSLEY (CHIEF SCIENTIFIC OFFICER) has made 0 purchases and 3 sales selling 469,051 shares for an estimated $3,169,591.
- DONGFANG LIU (CHIEF MEDICAL OFFICER) has made 0 purchases and 6 sales selling 220,000 shares for an estimated $1,616,356.
- DAVID C. HANLEY (CHIEF TECHNICAL OPERATIONS) sold 200,000 shares for an estimated $1,427,680
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NUVB Hedge Fund Activity
We have seen 116 institutional investors add shares of $NUVB stock to their portfolio, and 120 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MPM BIOIMPACT LLC removed 4,622,590 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $17,103,583
- MILLENNIUM MANAGEMENT LLC removed 4,140,674 shares (-85.3%) from their portfolio in Q4 2025, for an estimated $37,100,439
- BANK OF AMERICA CORP /DE/ added 3,180,263 shares (+505.5%) to their portfolio in Q4 2025, for an estimated $28,495,156
- AISLING CAPITAL MANAGEMENT LP removed 2,960,659 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $26,527,504
- OCTAGON CAPITAL ADVISORS LP removed 2,633,334 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $23,594,672
- PRICE T ROWE ASSOCIATES INC /MD/ added 2,424,109 shares (+852.2%) to their portfolio in Q4 2025, for an estimated $21,720,016
- CITADEL ADVISORS LLC removed 2,169,454 shares (-94.1%) from their portfolio in Q4 2025, for an estimated $19,438,307
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NUVB Analyst Ratings
Wall Street analysts have issued reports on $NUVB in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 12/01/2025
- Truist Securities issued a "Buy" rating on 11/24/2025
- Citizens issued a "Market Outperform" rating on 11/20/2025
- B. Riley Securities issued a "Buy" rating on 11/19/2025
- RBC Capital issued a "Outperform" rating on 11/04/2025
- Wedbush issued a "Outperform" rating on 10/13/2025
- Jefferies issued a "Buy" rating on 09/30/2025
To track analyst ratings and price targets for $NUVB, check out Quiver Quantitative's $NUVB forecast page.
$NUVB Price Targets
Multiple analysts have issued price targets for $NUVB recently. We have seen 8 analysts offer price targets for $NUVB in the last 6 months, with a median target of $11.0.
Here are some recent targets:
- David Nierengarten from Wedbush set a target price of $11.0 on 02/10/2026
- Leonid Timashev from RBC Capital set a target price of $12.0 on 01/21/2026
- Robert Burns from HC Wainwright & Co. set a target price of $17.0 on 01/12/2026
- Michael Yee from UBS set a target price of $10.0 on 01/07/2026
- Gregory Renza from Truist Securities set a target price of $11.0 on 11/24/2025
- Silvan Tuerkcan from Citizens set a target price of $10.0 on 11/20/2025
- Mayank Mamtani from B. Riley Securities set a target price of $12.0 on 11/19/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
